AEON Biopharma (AEON) Institutional Ownership $0.40 +0.01 (+1.28%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.39 -0.01 (-3.21%) As of 04/17/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for AEON Biopharma (NASDAQ:AEON)CurrentInstitutional OwnershipPercentage22.78%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$481.13MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$851.16M Get AEON Insider Trade Alerts Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AEON Institutional Buying and Selling by Quarter AEON Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/25/2025Polar Asset Management Partners Inc.2,762,688$1.49M0.0%-23.3%3.455% 2/19/2025Formidable Asset Management LLC689,182$372K0.1%+76.8%0.862% 2/17/2025Polar Asset Management Partners Inc.2,762,688$1.49M0.0%-23.3%3.455% 2/14/2025Blue Owl Capital Holdings LP3,049,361$1.65M0.4%-8.7%3.813% 11/16/2024Geode Capital Management LLC243,168$255K0.0%+30.1%0.622% 11/15/2024Polar Asset Management Partners Inc.3,599,918$3.78M0.1%-2.0%9.202% 11/15/2024HighTower Advisors LLC23,776$25K0.0%N/A0.061% 11/7/2024Caprock Group LLC62,686$66K0.0%N/A0.160% 8/14/2024Davidson Kempner Capital Management LP90,053$95K0.0%-75.4%0.230% 5/17/2024Shaolin Capital Management LLC21,380$248K0.0%-97.7%0.057% 5/10/2024Vanguard Group Inc.758,992$8.80M0.0%+261.8%2.008% 2/7/2024Formidable Asset Management LLC58,193$419K0.1%-9.5%0.157% 11/9/2023Formidable Asset Management LLC64,311$360K0.1%N/A0.723% 11/6/2023Atalaya Capital Management LP3,675,000$19.83M21.7%N/A41.283% (Data available from 1/1/2016 forward) AEON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AEON shares? During the previous two years, 10 institutional investors and hedge funds held shares of AEON Biopharma. The most heavily invested institutionals were Atalaya Capital Management LP ($19.83M), Vanguard Group Inc. ($8.80M), Blue Owl Capital Holdings LP ($1.65M), Polar Asset Management Partners Inc. ($1.49M), Formidable Asset Management LLC ($372K), Geode Capital Management LLC ($255K), and Shaolin Capital Management LLC ($248K).Learn more on AEON's institutional investors. What percentage of AEON Biopharma stock is owned by institutional investors? 22.78% of AEON Biopharma stock is owned by institutional investors. Learn more on AEON's institutional investor holdings. Which institutional investors have been buying AEON Biopharma stock? The following institutional investors have purchased AEON Biopharma stock in the last 24 months: Atalaya Capital Management LP ($3.68M), Vanguard Group Inc. ($549.21K), Formidable Asset Management LLC ($363.71K), Caprock Group LLC ($62.69K), Geode Capital Management LLC ($56.31K), and HighTower Advisors LLC ($23.78K). How much institutional buying is happening at AEON Biopharma? Institutional investors have bought a total of 4,730,690 shares in the last 24 months. This purchase volume represents approximately $1.99B in transactions. Which AEON Biopharma major shareholders have been selling company stock? The following institutional investors have sold AEON Biopharma stock in the last 24 months: Polar Asset Management Partners Inc. ($1.75M), Shaolin Capital Management LLC ($895.74K), Blue Owl Capital Holdings LP ($291.84K), Davidson Kempner Capital Management LP ($276.62K), and Formidable Asset Management LLC ($6.12K). How much institutional selling is happening at AEON Biopharma? Institutional investors have sold a total of 3,219,861 shares in the last 24 months. This volume of shares sold represents approximately $854.33M in transactions. Related Companies CMMB Major Shareholders LSTA Major Shareholders BFRG Major Shareholders LPCN Major Shareholders EDSA Major Shareholders LSB Major Shareholders UBX Major Shareholders BCTX Major Shareholders EGRX Major Shareholders BIVI Major Shareholders This page (NASDAQ:AEON) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AEON Stock Free AEON Stock Alerts